Recombinant Human LGALS7 Protein(Sumo Tag)
| Specifications | |
|---|---|
| Molecular Weight: | 30.8 kDa |
| Tag: | N-Sumo |
| Source: | E.coli |
| Purity: | > 90 % as determined by reducing SDS-PAGE. |
| Endotoxin Level: | < 1.0 EU per μg of the protein as determined by the LAL method |
| Format: | Lyophilized from a 0.2 μm filtered solution in PBS with 5% Trehalose and 5% Mannitol. |
| Additional Information | |
|---|---|
| Synonyms: | Gal-7;GAL7;Galectin 7B;Galectin-7;HKL-14;Human keratinocyte lectin 14;Keratinocyte lectin 14;Lectin galactoside binding soluble 7;Lectin;galactoside binding;soluble;7B;LEG7;LGALS7;LGALS7A;LGALS7B;P53 induced protein 1;p53-induced gene 1 protein;Pi7;PIG1;TP53I1 |
| Organism: | Human |
| Accn. No.: | P47929 |
Sequence Information
Ser2-Phe136
Background
LGALS7, also known as Galectin-7, is a member of the galectins family. The galectins are a family of beta-galactoside-binding proteins. There are at least 14 identified members of this family. Galectins share similarities in the CRD (the carbohydrate recognition domain). They are synthesized as cytosolic proteins. Though localized principally in the cytoplasm and lacking a classical signal peptide, galectins can also be stimulated to secretion by non-classical pathways or targeted to the nucleus. Galectins are implicated in modulating cell-cell and cell-matrix interactions. LGALS7 contains 1 galectin domain and is mainly expressed in stratified squamous epithelium. Galectin-7 could be involved in cell-cell and/or cell-matrix interactions necessary for normal growth control. LGALS7 is a pro-apoptotic protein that functions intracellularly upstream of JNK activation and cytochrome c release.
Price
776,00 €
